APA (7th ed.) Citation

Unglaub, J. M., Schlenk, R. F., Middeke, J. M., Krause, S. W., Kraus, S., Einsele, H., . . . Sauer, T. (2025). Venetoclax-based salvage therapy as a bridge to transplant is feasible and effective in patients with relapsed/refractory AML. Blood advances, 9(2), . https://doi.org/10.1182/bloodadvances.2024013086

Chicago Style (17th ed.) Citation

Unglaub, Julia Marie, et al. "Venetoclax-based Salvage Therapy as a Bridge to Transplant Is Feasible and Effective in Patients with Relapsed/refractory AML." Blood Advances 9, no. 2 (2025). https://doi.org/10.1182/bloodadvances.2024013086.

MLA (9th ed.) Citation

Unglaub, Julia Marie, et al. "Venetoclax-based Salvage Therapy as a Bridge to Transplant Is Feasible and Effective in Patients with Relapsed/refractory AML." Blood Advances, vol. 9, no. 2, 2025, https://doi.org/10.1182/bloodadvances.2024013086.